Breaks Categories: Stock Spotlights

ThursdayFeb 04, 2021 3:00 pm

BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) on the Verge of Changing History with Berubicin

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, has set sights on an encouraging future for glioblastoma patients with its upcoming Phase 2 trial of Berubicin. The article detailing this groundbreaking news quoted the company’s CEO John Climaco as saying, “Anthracyclines as a class of chemotherapy have been used for over 60 years to treat a variety of cancers… However, historically, anthracyclines have never been used to treat primary or metastatic brain cancers because scientists could not demonstrate that anthracyclines were able…

Continue Reading

ThursdayFeb 04, 2021 1:13 pm

BioMedNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Harnesses Blue Light, Innovative Technology for Cancer Imaging

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, is harnessing the virtues of blue light in a health-enhancing way. By utilizing the company’s proprietary i/Blue Imaging (TM) System with a contrast agent, surgeons will be able to better visualize the parameters of cancers and develop the appropriate response strategy. Imagin is developing its platform for use in bladder cancer surgery. It relies on Cysview, a drug that rapidly infiltrates cancer cells and causes them to glow bright pink under blue light. Cysview is administered just before surgery and the blue light is used endoscopically to locate and examine…

Continue Reading

FridayJan 29, 2021 3:08 pm

BioMedNewsBreaks – United Medical Equipment Business Solutions Network Inc. Poised Across Continuum of Health Care

United Medical Equipment (“UME,” “UMEBSNI”) continues to address unique testing needs created by the ongoing global pandemic. As part of the company’s efforts to provide essential services during the epidemic, UMEBSNI is a trusted supplier of FDA-approved COVID-19 rapid antigen test kits that detect coronavirus antibodies that appear in the bloodstream of infected individuals within 10 minutes. The test can also indicate whether a person has protection against the coronavirus. In addition, UMEBSNI offers a unique mobile solution with testing specialists and experienced medical staff members providing onsite COVID-19 Rapid Testing and solutions to implement employee safety. These on-call mobile…

Continue Reading

FridayJan 29, 2021 2:40 pm

BioMedNewsBreaks – MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Announces Promising Results from CyberAgrot Study

MustGrow (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0), an innovative agriculture biotech company focused on providing natural biological protection for high value crops, recently released potentially industry-changing results for its initial Colombia laboratory test. The study evaluated the effect of its proprietary mustard-derived organic biopesticide formulation on the disease Fusarium wilt TR4. MustGrow’s study, conducted and reported via third-party laboratory CyberAgrot SAS in Colombia using Instituto Colombiano Agropecuario (“ICA”) official protocols, reported 100% control of the disease. A recent article discussing this reads, “In the announcement, MustGrow outlined the CyberAgrot study results. Carefully adhering to ICA official protocols, the test evaluated…

Continue Reading

TuesdayJan 12, 2021 12:58 pm

BioMedNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Focuses on Multi-Omic Approach to Personalized Treatment Options

Predictive Oncology (NASDAQ: POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (“AI”) to personalized medicine and drug discovery. The company is building a business around an emerging approach to disease prevention and treatment that identifies the variability in genes, environment and lifestyle for each individual, and then uses that information to provide individualized treatments designed to ultimately improve patient outcomes. A recent article discussing this reads, “POAI realizes that ‘just genomics’ is not enough to deliver personalized therapeutic options. The company believes that a multi-omic approach to disease, or one that gathers data from…

Continue Reading

FridayJan 08, 2021 12:22 pm

BioMedNewsBreaks – MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) COO Shines the Spotlight on Proprietary Tech, Unique Value Proposition

MustGrow (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0), an innovative agriculture biotech company focused on providing natural biological protection for high value crops, was featured in a recent SmallCap-Investor interview. The company’s COO Colin Bletsky joined the interview to discuss MustGrow and its unique value proposition and ambitious plans for the future. Bletsky explained that a rigorous scientific process stands behind MustGrow’s proprietary technology, in which the company has invested more than $10 million. MustGrow has also conducted an estimated 110 studies in the field and worked with third-party companies, leading to the ownership of approximately 100 patents The company is…

Continue Reading

TuesdayJan 05, 2021 2:02 pm

BioMedNewsBreaks – United Medical Equipment Business Solutions Network Inc.’s App Assists with Well-Informed Decisions

United Medical Equipment (“UME”) has created a powerful app designed for health-care professionals, caregivers, students and family members who are providing direct and indirect patient care and education. Providing critical information and access to real-time tools, UME’s Medication Management app features more than a dozen different functionalities. The app enables access to a library for up-to-date information on medications and their indications, dosage, side effects, etc.; identification tools for medications not contained in original packaging; conversion systems for metric-U.S./Imperial quantities that includes weight, temperature, volume, and height; dosage converter for active medications/treatments; and much more. A recent article discussing this…

Continue Reading

MondayJan 04, 2021 2:34 pm

BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Shares Objectives for Berubicin Phase 2 Trial

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, recently hosted a webinar to discuss the clinical design for its upcoming Phase 2 trial. The trial will study its lead drug candidate, Berubicin, for the treatment of glioblastoma multiforme (“GBM”), an aggressive form of brain cancer currently considered incurable. Berubicin is an anthracycline that has demonstrated significant potential to effectively cross the blood-brain barrier and target central nervous system malignancies. The company’s Phase 2 trial will recruit 243 patients for side-by-side, real-time analysis…

Continue Reading

ThursdayDec 31, 2020 3:18 pm

BioMedNewsBreaks – Why United Medical Equipment Business Solutions Network Inc. Is ‘One to Watch’

United Medical Equipment (“UME”) is a provider of reliable resources and solutions to fit the ever-changing needs of an aging population that includes seniors and veterans, as well as those impacted by the COVID-19 pandemic. The company is uniquely poised to offer health care across the continuum of care with solutions that help providers work more proficiently, health care systems work smarter, and patients live healthier lives. UME operates nationwide with a corporate office located in Fort Worth, Texas. A recent article discussing the company reads, “United Medical Equipment provides services that have been thoroughly vetted, have a good reputation,…

Continue Reading

ThursdayDec 31, 2020 2:56 pm

BioMedNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Eyes Expansion of Proprietary Imaging Technology

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, assists surgeons to more effectively root out cancers in a minimally invasive manner by making it possible to better see the interior recesses of men and women during medical procedures. The company will launch its platform with the introduction of the i/Blue Imaging (TM) System, a proprietary imaging technology based on advanced optics and light sensors. The value of Imagin’s platform is that it makes surgery-revolutionizing technology more available to hospitals through the ability to adapt it to existing equipment. A recent article discussing Imagin’s solution reads, “The company’s initial…

Continue Reading